Showing paper detailed information


Citation Information


Analytical methods

Comparative study #1 #2
Chromatography LC LC
Ion source ESI ESI
Positive/Negative mode negative positive
Mass analyzer Q-Orbitrap Q-Orbitrap
Identification level MS/MS MS/MS

Sample information

Comparative study #1 #2
Country China China
Specimen plasma plasma
Marker function diagnosis diagnosis
Participants(Case) Cancer type lung cancer lung cancer
Stage
Number3131
Gender (M,F)19, 1219, 12
Mean age (range) (M,F)28-6428-64
Smoking status
Participants(Control) Type healthy healthy
Number3535
Gender (M,F)24, 1124, 11
Mean age (range) (M,F)23-6023-60
Smoking status

Data processing and metabolite identification

Data processing software XCMS
Database search OSI-SMMS

Statistical analysis

Differential analysis method OPLS-DA, Mann-Whitney U test
Classification method
Survival analysis method

Lung cancer-related metabolites identified in the paper

Metabolite Author-emphasized biomarkers Mean concentration (case) Mean concentration (control) Fold change (case/control) P-value FDR VIP
L-cysteine-glutathione gisulfide 3.19 2.01e-06 1.94
2, 4-diacetylphloroglucinol 2.78 1.17e-11 2.65
glycoursodeoxycholic acid 1.88 7.35e-03 1.26
glycoursodeoxycholic acid 1.70 8.75e-03 1.20
phenylalanine 1.58 1.15e-04 1.32
2,3-dihydroxybenzoic acid 1.53 1.76e-04 1.52
stearamide 1.46 1.42e-03 1.29
6-thioxanthine 1.36 2.42e-04 1.27
D-mannose 1.35 6.99e-05 1.82
Dl-P-hydroxyphenyl lactic acid 1.32 4.04e-03 1.40
D(-)-arginine 1.30 4.56e-04 1.29
hydroxyphenyllactic acid 1.30 0.01 1.30
3-carboxybenzadehyde 1.25 1.49e-03 1.42
L-tyrosine 1.25 0.01 1.30
2-methylmercaptobenzothiazole 0.89 1.68e-03 1.22
alpha-pinene 0.88 5.51e-05 1.74
dodecylamine 0.86 1.82e-03 1.48
cholesteryl laurate 0.83 6.37e-03 1.22
xanthine V 0.80 3.13e-07 1.89
calcifediol 0.76 1.29e-03 1.32
D-pantothenic acid 0.73 3.68e-03 1.30
pyroglutamic acid 0.69 9.47e-04 1.72
malic acid 0.69 7.49e-04 1.41
uridine 0.68 1.11e-04 1.84
4-pyridoxate V 0.66 7.47e-05 1.31
cis-11,14-eicosadienoic acid 0.66 1.68e-03 1.51
D-(+)-Malic acid 0.64 9.16e-08 2.03
cis-8,11,14-eicosatrienoic acid 0.64 4.41e-04 1.42
docosahexaenoic acid 0.58 2.73e-04 1.67
threonate 0.57 1.02e-06 2.06
3-aminopentanedioic acid 0.56 2.21e-08 2.13
10-hydroxydecanoic acid 0.55 3.94e-05 1.85
7z,10z,13z-hexadecatrienoic acid 0.55 7.96e-04 1.46
arachidonic acid 0.54 5.11e-06 1.97
Dl-glutamic acid 0.54 1.15e-08 2.17
All-cis-4,7,10,13,16-docosapentaenoic acid 0.53 4.22e-04 1.59
canthaxanthine 0.53 1.28e-04 1.68
L-pyroglutamic acid 0.52 8.00e-07 2.07
Phe-Phe 0.49 9.42e-05 1.82
10-undecenoic acid 0.44 1.91e-06 2.14
2-aminopropanol 0.44 0.02 1.48
D-Glu V 0.42 4.05e-03 1.75
5-pregnane-3,20-dione 0.42 0.04 1.58
butylamine 0.41 2.38e-08 2.08
glycerophosphoric acid 0.32 1.17e-08 2.59
3-methylcrotonyl glycine 0.29 9.85e-03 1.59
hypoxanthine 0.28 1.83e-07 2.43
8(R)-hydroxy-(5Z,9E,11Z,14Z)-eicosatetraenoic acid 0.27 1.08e-04 2.33
hypoxanthine 0.24 2.12e-07 2.69
inosine 0.20 6.44e-06 2.34
N-oleoylethanolamine 0.05 1.07e-07 2.56
inosine 0.03 1.99e-04 2.01
N-acetyl-5-hydroxytryptamine 0.02 5.37e-08 2.44
Metabolite Author-emphasized biomarkers Cutoff value AUROC (95%CI) Sensitivity (%) Specificity (%) Accuracy (%)
L-cysteine-glutathione gisulfide
2, 4-diacetylphloroglucinol
glycoursodeoxycholic acid
glycoursodeoxycholic acid
phenylalanine
2,3-dihydroxybenzoic acid
stearamide
6-thioxanthine
D-mannose
Dl-P-hydroxyphenyl lactic acid
D(-)-arginine
hydroxyphenyllactic acid
3-carboxybenzadehyde
L-tyrosine
2-methylmercaptobenzothiazole
alpha-pinene
dodecylamine
cholesteryl laurate
xanthine V
calcifediol
D-pantothenic acid
pyroglutamic acid
malic acid
uridine
4-pyridoxate V
cis-11,14-eicosadienoic acid
D-(+)-Malic acid
cis-8,11,14-eicosatrienoic acid
docosahexaenoic acid
threonate
3-aminopentanedioic acid
10-hydroxydecanoic acid
7z,10z,13z-hexadecatrienoic acid
arachidonic acid
Dl-glutamic acid
All-cis-4,7,10,13,16-docosapentaenoic acid
canthaxanthine
L-pyroglutamic acid
Phe-Phe
10-undecenoic acid
2-aminopropanol
D-Glu V
5-pregnane-3,20-dione
butylamine
glycerophosphoric acid
3-methylcrotonyl glycine
hypoxanthine
8(R)-hydroxy-(5Z,9E,11Z,14Z)-eicosatetraenoic acid
hypoxanthine
inosine
N-oleoylethanolamine
inosine
N-acetyl-5-hydroxytryptamine

Paper graphical summary